For the anti‐tumor activity of Oxysophocarpine, it has been identified that Oxysophocarpine suppresses oral squamous cell carcinoma by targeting the Nrf2/HO‐1 axis and inhibits H22 liver cancer cells growth.11 Here, HMOX1 is linked to oral cavity squamous cell carcinoma.